Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma Blood
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045 JNCI-J NATL CANCER I
Generation of an inducible dCas9-SAM human PSC line for endogenous gene activation Front Cell Dev Biol
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment EUR J HAEMATOL
Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction during Pregnancy on Fetal Brain Development Detected by Neurosonography: A Secondary Analysis of a Randomized Clinical Trial (IMPACT BCN) Fetal Diagn Ther
COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation. NAT COMMUN